Neurovascular Pharmacology of Migraine; Epigenetics and Sex Hormones

Chan KY, Labruijere S, de Vries R, Danser AHJ, Villalón CM, MaassenVanDen Brink A. Cranioselectivity of sumatriptan revisited. J. Headache Pain, 2010 oct; 11 Suppl.1):203 Labruijere S, Chan KY, van Houten ELAF, de Vries R, Kramer P, Danser AHJ, Villalón CM, Visser JA, MaassenVanDen Brink A. The effect of DHT on vascular reactivity. J. Headache Pain, 2010 oct; 11 Suppl.1):201 Labruijere S, Chan KY, de Vries R, Garrelds IM, Danser AHJ, Villalon CM, MaassenVanDenBrink A. The role of 17beta-estradiol withdrawal in the neurovascular pathophysiology of migraine. Trabajos del Instituto Cajal. Tomo LXXXIII, 2011 nr 179 Labruijere S, Chan KY, Danser AHJ, Villalón CM, Edvinsson L, MaassenVanDenBrink A. The effect of sumatriptan and telcagepant on CGRP-induced dilation in human isolated middle meningeal arteries. Cephalalgia, 2011 jul; 31(1 Suppl): PS1-127 K.Y. Chan, S.A.L. Borst, S. Labruijere, A.H.J. Danser, A. MaassenVanDenBrink. The non-genomic and genomic effects of 17beta-estradiol on cgrp-induced relaxations in the porcine coronary artery. S. Labruijere, R. de Vries, A.H.J. Danser, G.S. Cottrell, A. MaassenVanDenBrink. Endothelin-converting-enzyme 1 inhibition and CGRP receptor recycling in human coronary and middle meningeal arteries. The Journal of Headache and Pain, Volume 14, Supplement 1, February 2013 S. Labruijere, M.B. Ramírez-Rosas, R. de Vries, A.H.Jan. Danser, A. MaassenVanDenBrink. Sumatriptan and dihydroergotamine in isolated distal human